Related Experiment Video

Updated: Mar 13, 2026

A Reproducible Intensive Care Unit-Oriented Endotoxin Model in Rats
05:56

A Reproducible Intensive Care Unit-Oriented Endotoxin Model in Rats

Published on: February 20, 2021

2.5K

IL-1 receptor antagonist in sepsis: new findings with old data?

David Grimaldi1, Eduardo Wilfrido Goicoechea Turcott1, Fabio Silvio Taccone1

  • 1Department of Intensive Care, Erasme Hospital, Université Libre de Bruxelles, Bruxelles, Belgium.

Journal of Thoracic Disease
|October 18, 2016
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Use of Animal Model of Sepsis to Evaluate Novel Herbal Therapies
07:34

Use of Animal Model of Sepsis to Evaluate Novel Herbal Therapies

Published on: April 11, 2012

20.2K
Cecal Ligation Puncture Procedure
11:53

Cecal Ligation Puncture Procedure

Published on: May 7, 2011

56.5K

Related Experiment Videos

Last Updated: Mar 13, 2026

A Reproducible Intensive Care Unit-Oriented Endotoxin Model in Rats
05:56

A Reproducible Intensive Care Unit-Oriented Endotoxin Model in Rats

Published on: February 20, 2021

2.5K
Use of Animal Model of Sepsis to Evaluate Novel Herbal Therapies
07:34

Use of Animal Model of Sepsis to Evaluate Novel Herbal Therapies

Published on: April 11, 2012

20.2K
Cecal Ligation Puncture Procedure
11:53

Cecal Ligation Puncture Procedure

Published on: May 7, 2011

56.5K

Related Concept Videos

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

693
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
693

Articles linked to this work by shared authors, journal, and citation graph.

Initiating transformative medical practices to address environmental challenges - proceedings of "Santé en 2050", the French national conference on healthcare adaptation.

Reviews on environmental health·2026

Increasing propellant gas emissions from pressurized metered-dose inhalers in obstructive lung diseases in France over 11 years.

Respiratory research·2026

Health-related quality of life trajectories one year after COVID-19-induced ARDS: A secondary analysis of the CONFIDENT trial.

Annals of intensive care·2026

An EACVI survey assessing the awareness of cardiovascular imaging's environmental impact among cardiovascular imagers.

European heart journal. Imaging methods and practice·2026

Plasma levels of intestinal fatty acid-binding protein and citrulline are not associated with severe upper gastrointestinal ischemic lesions after out-of-hospital cardiac arrest: an ancillary study of the ENTRACT trial.

Resuscitation plus·2025

Carbon footprint of direct oral anticoagulants in atrial fibrillation and venous thromboembolism.

Haematologica·2025

Impact of pleural anthracosis severity on the structure and function of subcarinal lymph nodes.

Journal of thoracic disease·2026

Idiopathic pulmonary fibrosis and interleukins: a bibliometric analysis [1999-2025].

Journal of thoracic disease·2026

Factors associated with Acinetobacter baumannii lower respiratory tract infection in the respiratory intensive care unit patients: a cross-sectional observational study.

Journal of thoracic disease·2026

Efficacy and safety of TQC3403 in patients with chronic obstructive pulmonary disease (COPD): a multicenter, randomized, open-label, phase 3 equivalence trial.

Journal of thoracic disease·2026

Construction and validation of an acute exacerbation risk score for fibrotic idiopathic interstitial pneumonia.

Journal of thoracic disease·2026

LTB4R inhibits apoptosis and induces radiosensitivity by promoting the PI3K/AKT pathway in esophageal squamous cell carcinoma.

Journal of thoracic disease·2026

Interleukin-39 aggravates sepsis by inducing self-sustaining neutrophil activation in the lungs via the CXCL1-CXCR2 pathway.

International journal of biological sciences·2026

Mechanisms and clinical research progress of IL-6-mediated crosstalk between the alveolar microenvironment and the immune system in patients with severe pneumonia undergoing mechanical ventilation.

Frontiers in immunology·2026

Roles of IL-34 in neurological diseases: neuroprotection, inflammatory regulation, and myeloid plasticity.

Frontiers in immunology·2026

Inflammatory remodeling of the ovarian microenvironment in premature ovarian insufficiency: mechanisms and therapeutic opportunities.

Frontiers in immunology·2026

Recent understanding of immunometabolic remodeling in pulmonary macrophages: homeostasis, chronic respiratory diseases, and therapeutic targeting.

Frontiers in pharmacology·2026

RAC2 orchestrates immune cell actin remodeling and migration.

Frontiers in immunology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us